Literature DB >> 16607569

Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesis.

Caroline J Taylor1, Kouros Motamed, Brenda Lilly.   

Abstract

Angiogenesis, a critical process in both health and disease, is mediated by a number of signaling pathways. Although proangiogenic stimuli, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and the phorbol ester phorbol-12 myristate-13 acetate (PMA) are known to promote blood vessel formation, their downstream targets are ill defined. We sought to investigate the signaling pathways required for vessel assembly by utilizing a three-dimensional collagen matrix in which human umbilical vein endothelial cells (HUVECs) form tubular structures. Our data show that PMA is sufficient for the induction of angiogenesis, and that protein kinase C (PKC) is necessary for this process. Evaluation of PKC isoforms alpha and sigma revealed that these proteins are uniquely regulated. Characterization of an additional PMA target, protein kinase D (PKD) demonstrated that this enzyme becomes phosphorylated in HUVECs, and may therefore be involved in proangiogenic signaling. Further examination of downstream effectors of PKC showed that extracellular signal-regulated kinase (ERK) is critical for angiogenesis, and is accordingly phosphorylated in response to PMA. Surprisingly however, phosphorylation of ERK is independent of PKC activity. In addition, we show that the PKC target sphingosine kinase (SPK) is required for vessel formation. These findings illustrate the complexities of blood vessel formation, and suggest that activators utilize multiple independent pathways to invoke a complete angiogenic response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16607569     DOI: 10.1007/s10456-006-9028-y

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  15 in total

1.  Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation.

Authors:  Hesham M El-Shewy; Souzan A Abdel-Samie; Abdelmohsen M Al Qalam; Mi-Hye Lee; Kazuyuki Kitatani; Viviana Anelli; Ayad A Jaffa; Lina M Obeid; Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2011-10-20

2.  Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.

Authors:  Bin Ren; James Hale; Sowmya Srikanthan; Roy L Silverstein
Journal:  Blood       Date:  2011-03-25       Impact factor: 22.113

3.  ADAMTS-4 and biglycan are expressed at high levels and co-localize to podosomes during endothelial cell tubulogenesis in vitro.

Authors:  Masanari Obika; Robert B Vernon; Michel D Gooden; Kathleen R Braun; Christina K Chan; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

4.  Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).

Authors:  Klaus Podar; Marc S Raab; Jing Zhang; Douglas McMillin; Iris Breitkreutz; Yu-Tzu Tai; Boris K Lin; Nikhil Munshi; Teru Hideshima; Dharminder Chauhan; Kenneth C Anderson
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

5.  Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro.

Authors:  Yoshito Takeda; Alexander R Kazarov; Catherine E Butterfield; Benjamin D Hopkins; Laura E Benjamin; Arja Kaipainen; Martin E Hemler
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

6.  PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting.

Authors:  Martina Monti; Sandra Donnini; Lucia Morbidelli; Antonio Giachetti; Daria Mochly-Rosen; Paolo Mignatti; Marina Ziche
Journal:  J Mol Cell Cardiol       Date:  2013-07-20       Impact factor: 5.000

7.  Sphingosine 1-phosphate and sphingosine kinase are involved in a novel signaling pathway leading to acrosomal exocytosis.

Authors:  Laila Suhaiman; Gerardo A De Blas; Lina M Obeid; Alberto Darszon; Luis S Mayorga; Silvia A Belmonte
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

Review 8.  Guidance from above: common cues direct distinct signaling outcomes in vascular and neural patterning.

Authors:  Maria V Gelfand; Shangyu Hong; Chenghua Gu
Journal:  Trends Cell Biol       Date:  2009-02-04       Impact factor: 20.808

9.  Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization.

Authors:  Fabiana Baganha; Rob C M de Jong; Erna A Peters; Wietske Voorham; J Wouter Jukema; Mirela Delibegovic; Margreet R de Vries; Paul H A Quax
Journal:  Angiogenesis       Date:  2021-02-07       Impact factor: 9.596

10.  VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx.

Authors:  Siu P Ngok; Rory Geyer; Miaoliang Liu; Antonis Kourtidis; Sudesh Agrawal; Chuanshen Wu; Himabindu Reddy Seerapu; Laura J Lewis-Tuffin; Karen L Moodie; Deborah Huveldt; Ruth Marx; Jay M Baraban; Peter Storz; Arie Horowitz; Panos Z Anastasiadis
Journal:  J Cell Biol       Date:  2012-12-17       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.